8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24098039 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Dianbao Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cells and Regenerative Medicine, Key Laboratory of Cell Biology, National Health Commission of China, and Key Laboratory of Medica…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Liaoning Province, China, Basic Scientific Research Project for Colleges and Universities from Department of Education of Liaoning Province, China, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Colorectal cancer (CRC) is one of the most common malignant tumors with a high lethal rate globally, and novel strategies for its prevention and therapy are urgently needed. In our previous work, 8-methoxyflindersine (8-MF), a quinoline alkaloid, was isolated from the Dictamni cortex, and its bioactivities were largely unknown. In this study, we found that 8-MF significantly inhibited cell viability in the CRC cell lines LoVo and RKO. The 8-MF-induced CRC cell apoptosis, as well as cell cycle disorder, were further verified by cyclins dysregulation in mRNA and protein levels. Further, the activation of MAPK family members p38 and ERK1/2 was observed after 8-MF treatment. Moreover, the protein–protein interaction of 8-MF with cyclins and MAPKs was demonstrated using the STRING database. The 8-MF could bind to p38 and ERK1/2 proteins in molecular docking. Taken together, we found that 8-MF induced apoptosis and cell cycle disorder involving MAPK signaling activation in CRC cells, indicating 8-MF as a novel lead compound candidate for the development of anti-tumor drugs for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cells and Regenerative Medicine, Key Laboratory of Cell Biology, National Health Commission of China, and Key Laboratory of Medical Cell Biology, Ministry of Education of China, China Medical Universi…
- Department of Natural Products Chemistry, School of Pharmacy, China Medical University, Shenyang 110122, China.
- Central Laboratory, School of Pharmacy, China Medical University, Shenyang 110122, China.
ORCID-Profile: Dianbao Zhang, Tao Liu
Förderung
- the Natural Science Foundation of Liaoning Province, China
- Basic Scientific Research Project for Colleges and Universities from Department of Education of Liaoning Province, China
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province, China
- Basic Scientific Research Project for Colleges and Universities from the Department of Education of Liaoning Province, China
Zitieren
APA
Zhang, D., Fu, Y., Liu, Y., Wu, Y., Chen, J., Zhang, L., Wang, R., Chen, Z., & Liu, T. (2023). 8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098039
Vancouver
Zhang D, Fu Y, Liu Y, Wu Y, Chen J, Zhang L, et al. 8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098039
BibTeX
@article{Zhang2023,
author = {Zhang, Dianbao and Fu, Yunmei and Liu, Ying and Wu, Yifan and Chen, Jiayu and Zhang, Luting and Wang, Rui and Chen, Zaixing and Liu, Tao},
title = {8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24098039}
}
EUVIMED